ReviewInternational journal of molecular sciences2014

Low-dose interleukin-2 therapy: a driver of an imbalance between immune tolerance and autoimmunity.

Agata KosmaczewskaPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.